Verition Fund Management »

Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Verition Fund Management

Quarter-by-quarter ownership of Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Karyopharm Therapeutics Inc note 3.000%10/1

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics Inc note 3.000%10/1 held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics Inc note 3.000%10/1 by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $843k 1.4k 620.59
2023-06-30 $928k 1.4k 682.50
2022-03-31 $5.3M 6.3M 0.85
2021-12-31 $5.2M 6.3M 0.82
2021-09-30 $3.3M 4.4M 0.75
2020-12-31 $8.3M 6.6M 1.26
2020-09-30 $6.7M 5.6M 1.20
2020-06-30 $7.8M 5.6M 1.40
2020-03-31 $8.7M 6.1M 1.43
2019-12-31 $11M 7.8M 1.43